| [1] 袁南兵,龙洋,张祥迅,等. 自体富血小板凝胶治疗糖尿病难治性皮肤溃疡作用机制的初步探讨[J]. 四川大学学报：医学版,2009, 40(2):292-294.[2] Weibrich G,Kleis WK,Hafner G,et al. Comparison of platelet, leukocyte, and growth factor levels in point-of-care platelet-enriched plasma, prepared using a modified Curasan kit, with preparations received from a local blood bank. Clin Oral Implants Res.2003;14(3):357-362.[3] Leitner GC, Gruber R, Neumüller J,et al. Platelet content and growth factor release in platelet-rich plasma: a comparison of four different systems. Vox Sang.2006;91(2):135-139.[4] Anitua E. Plasma rich in growth factors: preliminary results of use in the preparation of future sites for implants.nt J Oral Maxillofac Implants. 1999;14(4):529-535.[5] Anitua E,Aguirre JJ,Algorta J,et al.Effectiveness of autologous preparation rich in growth factors for the treatment of chronic cutaneous ulcers. J Biomed Mater Res B Appl Biomater.2008;84(2):415-421.[6] Sanchez M,Anitua E,Azofra J,et al.Comparison of surgically repaired Achilles tendon tears using platelet-rich fibrin matrices. Am J Sports Med.2007;35:245-251.[7] Weibrich G,Kleis WK,Hitzler WE,et al.Comparison of the platelet concentrate collection system with the plasma-rich-in- growth-factors kit to produce platelet-rich plasma: a technical report. Int J Oral Maxillofac Implants. 2005;20(1):118-123.[8] Tamimi FM,Montalvo S,Tresguerres I,et al. A comparative study of two methods for obtaining platelet-rich plasma.J Oral Maxillofac Surg.2007;65(6):1084-1093.[9] Weibrich G,Kleis WK,Buch R,et al. The Harvest Smart PRePTM system versus the Friadent-Schütze platelet-rich plasma kit. Clin Oral Implants Res. 2003;14(2):233-239.[10] Marlovits S,Mousavi M,Gäbler C,et al.A new simplified technique for producing platelet-rich plasma: a short technical note.Eur Spine J.2004;13(Suppl. 1):s102-s106.[11] Christensen K,Vang S,Brady C,et al. Autologous platelet gel: an in vitro analysis of platelet-rich plasma using multiple cycles.J Extra Corpor Technol. 2006;38(3):249-253.[12] Mazzucco L,Balbo V,Cattana E,et al. Platelet-rich plasma and platelet gel preparation using Plateltex. Vox Sang.2008;94(3): 202-208.[13] Uggeri J,Belletti S,Guizzardi S,et al.Dose-dependent effects of platelet gel releasate on activities of human osteoblasts.J Periodontol.2007;78(10):1985-1991.[14] Cenni E,Ciapetti G,Pagani S,et al.Effects of activated platelet concentrates on human primary cultures of fibroblasts and osteoblasts.J Periodontol.2005;76(3):323-328.[15] Soffer E,Ouhayoun JP,Dosquet C,et al. Effects of platelet lysates on select bone cell functions. Clin Oral Implants Res. 2004;15(5):581-588.[16] Lindeboom JA,Mathura KR,Aartman IH,et al.Influence of the application of platelet-enriched plasma in oral mucosal wound healing. Clin Oral Implants Res.2007;18(1):133-139.[17] Rozman P,Bolta Z. Use of platelet growth factors in treating wounds and soft-tissue injuries.Acta Dermatovenerol Alp Panonica Adriat.2007;16(4):156-165.[18] Thor A,Franke-Stenport V,Johansson CB,et al. Early bone formation in human bone grafts treated with platelet-rich plasma: preliminary histomorphometric results. Int J Oral Maxillofac Surg. 2007;36(12):1164-1171. [19] Everts PA,Devilee RJ,Oosterbos CJ,et al.Autologous platelet gel and fibrin sealant enhance the efficacy of total knee arthroplasty: improved range of motion, decreased length of stay and a reduced incidence of arthrofibrosis. Knee Surg Sports Traumatol Arthrosc. 2007;15(7):888-894.[20] Gardner MJ,Demetrakopoulos D,Klepchick PR,et al.The efficacy of autologous platelet gel in pain control and blood loss in total knee arthroplasty. An analysis of the haemoglobin, narcotic requirement and range of motion. Int Orthop.2007; 31(3):309-313.[21] Choukroun J,Adda F,Schoeffler C,et al.Une opportunite´ en paro-implantologie: le PRF. Implantodontie.2001;42:55-62.[22] Dohan DM,Choukroun J,Diss A,et al.Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part I: technological concepts and evolution.Oral Surg Oral Med Oral Pathol Oral Radiol Endod.2006;101(3):e37-e44. [23] Dohan DM,Del Corso M,Charrier JB.Cytotoxicity analyses of Choukroun's platelet-rich fibrin (PRF) on a wide range of human cells: The answer to a commercial controversy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod.2007;103(5): 587-593.[24] Dohan DM,Choukroun J,Diss A,et al.Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part II: platelet-related biologic features. Oral Surg Oral Med Oral Pathol Oral Radiol Endod.2006;101(3):e45-e50.[25] Dohan DM,Choukroun J,Diss A,et al.Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part III: leucocyte activation: a new feature for platelet concentrates?Oral Surg Oral Med Oral Pathol Oral Radiol Endod.2006;101(3): e51-e55.[26] Dohan Ehrenfest DM,Diss A,Odin G,et al.In vitro effects of Choukroun's PRF (platelet-rich fibrin) on human gingival fibroblasts,dermal prekeratinocytes, preadipocytes, and maxillofacial osteoblasts in primary cultures. Oral Surg Oral Med Oral Pathol Oral Radiol Endod.2009;108(3):341-352.[27] Jorgensen B,Karlsmark T,Vogensen H,et al.A Pilot Study of Leucopatch, an Autologous, Additive-Free,Platelet-Rich Fibrin for the Treatment of Recalcitrant Chronic Wounds to Determine Safety. Int J Low Extrem Wounds.2011; 2011;10(4):218-223..[28] Lee EH,Kim JY, Kweon HY,et al. A combination graft of low-molecular-weight silk fibroin with Choukroun platelet-rich fibrin for rabbit calvarial defect. Oral Surg Oral Med Oral Pathol Oral Radiol Endod.2010;109(5):e33-e38.[29] Simonpieri A,Del Corso M,Vervelle A,et al.Current Knowledge and Perspectives for the Use of Platelet-Rich Plasma (PRP) and Platelet-Rich Fibrin (PRF) in Oral and Maxillofacial Surgery. Part 2: Bone Graft, Implant and Reconstructive Surgery. Curr Pharm Biotechnol. 2012;13(7):1231-1256[30] Simonpieri A,Del Corso M,Sammartino G,et al.The relevance of Choukroun's platelet-rich fibrin and metronidazole during complex maxillary rehabilitations using bone allograft. Part I: a new grafting protocol.Implant Dent. 2009;18(2):102-111 .[31] Simonpieri A,Del Corso M,Sammartino G,et al.The relevance of Choukroun's platelet-rich fibrin and metronidazole during complex maxillary rehabilitations using bone allograft. Part II: Implant surgery, prosthodontics, and survival.Implant Dent. 2009;18(3):220.[32] Sammartino G,Dohan Ehrenfest DM, Carile F,et al. Prevention of hemorrhagic complications after dental extractions into open heart surgery patients under anticoagulant therapy: the use of L-PRF.J Oral Implantol. 2011;37(6):681-690.[33] Dohan ED,Rasmusson L,Albrektsson T.Classification of platelet concentrates: from pure platelet-rich plasma (P-PRP) to leucocyte- and platelet-rich fibrin (L-PRF). Trends Biotechnol. 2009;27(3):158-167. |
